Recombinant growth hormone for idiopathic short stature in children and adolescents-Reference-Cited by-同舟云学术

Recombinant growth hormone for idiopathic short stature in children and adolescents

Published:2007-07-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bryant Jackie¹,Baxter Louise¹,Cave Carolyn B¹,Milne Ruairidh¹

Affiliation:

1. Southampton University; Wessex Institute for Health Research and Development; Mailpoint 728, Biomedical Sciences Building Bassett Crescent East Southampton Hants UK SO16 7PX

Publisher

Wiley

Subject

Pharmacology (medical)

Reference40 articles.

1. Growth hormone treatment in non-growth hormone-deficient children: effects of stopping treatment;Ackland;Acta Paediatrica Scandinavica Supplement,1990

2. The growth and cardiovascular effects of high-dose growth hormone therapy in idiopathic short stature;Barton;Clinical Endocrinology,1995

3. Effects of growth hormone in short, slowly growing children without growth hormone deficiency. Australasian Paediatric Endocrine Group;Cowell;Acta Paediatrica Scandinavica Supplement,1990

4. Idiopathic short stature: results of a one-year controlled study of human growth hormone treatment. Genentech Collaborative Study Group;Genentech;The Journal of Pediatrics,1989

5. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature;Kamp;Archives of Diseases of Childhood,2002

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and laboratory characteristics but not response to treatment can distinguish children with definite growth hormone deficiency from short stature unresponsive to stimulation tests;Frontiers in Endocrinology;2024-03-01

2. Growth hormone effect on body composition of children born small for gestational age: a systematic review;Jornal de Pediatria;2023-05

3. Hsa_circ_0008870 suppresses bone formation of growth plate through inhibition of miR-185-3p/ MAPK1 axis in idiopathic short stature;Frontiers in Bioengineering and Biotechnology;2022-10-11

4. The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study;Journal of Pediatric Endocrinology and Metabolism;2022-10-07

5. Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment;Frontiers in Endocrinology;2022-09-07